https://harmreduction.eu/2025-10-20https://harmreduction.eu/resources/2022-01-03https://harmreduction.eu/resources/dcr/2022-01-02https://harmreduction.eu/resources/dcr/a-safe-place-to-use-drugs-lessons-from-europes-supervised-consumption-sites/https://harmreduction.eu/resources/dcr/supervised-injection-sites-are-coming-to-the-united-states-heres-what-you-should-know/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-as-a-setting-to-address-hcv-current-practice-and-future-capacity-2018/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-in-europe-orgnisational-overview-2014/https://harmreduction.eu/resources/dcr/geography-of-safe-spaces/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-in-the-netherlands-2018/https://harmreduction.eu/resources/dcr/perspectives-on-drugs-drug-consumption-rooms-an-overview-of-provision-and-evidence-emccda-2018/https://harmreduction.eu/resources/dcr/dutch-drug-consumption-rooms/https://harmreduction.eu/resources/dcr/success-and-challenges-20-years-of-drug-consumption-rooms-in-the-netherlands/https://harmreduction.eu/resources/dcr/prospective-client-survey-and-participatory-process-ahead-of-opening-a-mobile-drug-consumption-room-in-lisbon/https://harmreduction.eu/resources/dcr/project-solidify-supervised-drug-consumption-facilities-to-instill-harm-reduction-and-social-cohesion-at-local-levels/https://harmreduction.eu/resources/dcr/accidental-intimacy-transformative-emotion-and-the-sydney-medically-supervised-injecting-centre/https://harmreduction.eu/resources/dcr/beyond-failure-the-generative-effects-of-unsuccessful-proposals-for-supervised-drug-consumption-sites-scs-in-melbourne-australia/https://harmreduction.eu/resources/dcr/beyond-safer-injectinghealth-and-social-needs-and-acceptance-of-support-among-clients-of-a-supervised-injecting-facility/https://harmreduction.eu/resources/dcr/creating-and-sustaining-cooperative-relationships-between-supervised-injection-services-and-police-a-qualitative-interview-study-of-international-stakeholders/https://harmreduction.eu/resources/dcr/drug-consumption-facilities-in-europe-and-the-establishment-of-supervised-injecting-centres-in-australia/https://harmreduction.eu/resources/dcr/enhancing-consumer-participation-in-a-medically-supervised-injecting-centre-through-participatory-action-research/https://harmreduction.eu/resources/dcr/establishing-supervised-injecting-facilities-a-responsible-way-to-help-minimise-harm/https://harmreduction.eu/resources/dcr/establishing-the-melbourne-injecting-drug-user-cohort-study-mix-rationale-methods-and-baseline-and-twelve-month-follow-up-results/https://harmreduction.eu/resources/dcr/high-hiv-testing-and-low-hiv-prevalence-among-injecting-drug-users-attending-the-sydney-medically-supervised-injecting-centre/https://harmreduction.eu/resources/dcr/injecting-related-injury-and-disease-among-clients-of-a-supervised-injecting-facility/https://harmreduction.eu/resources/dcr/process-and-predictors-of-drug-treatment-referral-and-referral-uptake-at-the-sydney-medically-supervised-injecting-centre/https://harmreduction.eu/resources/dcr/supervised-injecting-facilities-how-much-evidence-is-enough/https://harmreduction.eu/resources/dcr/the-case-for-a-second-safe-injecting-facility-sif-in-sydney/https://harmreduction.eu/resources/dcr/the-impact-of-a-supervised-injecting-facility-on-ambulance-call-outs-in-sydney-australia/https://harmreduction.eu/resources/dcr/the-impact-of-oxycontin-reformulation-at-the-sydney-medically-supervised-injecting-centre-pros-and-cons/https://harmreduction.eu/resources/dcr/salas-de-consumo-de-drogas-situando-o-debate-no-brasil/https://harmreduction.eu/resources/dcr/a-community-based-report-on-albertas-supervised-consumption-service-effectiveness/https://harmreduction.eu/resources/dcr/acceptability-and-design-preferences-of-supervised-injection-services-among-people-who-inject-drugs-in-a-mid-sized-canadian-city/https://harmreduction.eu/resources/dcr/ambivalence-about-supervised-injection-facilities-among-community-stakeholders/https://harmreduction.eu/resources/dcr/arches-report-to-mayor-and-city-council/https://harmreduction.eu/resources/dcr/assessing-support-for-supervised-injection-services-among-community-stakeholders-in-london-canada/https://harmreduction.eu/resources/dcr/at-a-glance-supervised-injection-services-a-community-based-response-to-the-opioid-crisis-in-the-city-of-ottawa-canada/https://harmreduction.eu/resources/dcr/attendance-drug-use-patterns-and-referrals-made-from-north-americas-first-supervised-injection-facility/https://harmreduction.eu/resources/dcr/balises-pour-les-etablissements-de-sante/2022-04-04https://harmreduction.eu/resources/dcr/bc-overdose-prevention-services-guide-2019/https://harmreduction.eu/resources/dcr/best-practice-guidelines-implementing-supervised-injection-services/https://harmreduction.eu/resources/dcr/changes-in-injecting-practices-associated-with-the-use-of-a-medically-supervised-safer-injection-facility/https://harmreduction.eu/resources/dcr/changes-in-public-order-after-the-opening-of-a-medically-supervised-safer-injecting-facility-for-illicit-injection-drug-users/https://harmreduction.eu/resources/dcr/changing-risk-and-presentation-of-overdose-associated-with-consumption-of-street-drugs-at-a-supervised-injection-site-in-vancouver-canada/https://harmreduction.eu/resources/dcr/circumstances-of-first-injection-among-illicit-drug-users-accessing-a-medically-supervised-safer-injection-facility/https://harmreduction.eu/resources/dcr/consumption-and-treatment-services-cts-planning-study-for-the-city-of-cambridge/https://harmreduction.eu/resources/dcr/consumption-and-treatment-services-application-guide/https://harmreduction.eu/resources/dcr/consumption-spaces-consultation-and-needs-assessment-winnipeg/https://harmreduction.eu/resources/dcr/crime-disorder-near-the-sheldon-m-chumir-health-centres-supervised-consumption-services-scs-facility/https://harmreduction.eu/resources/dcr/critical-studies-of-harm-reduction-overdose-response-in-uncertain-political-times/https://harmreduction.eu/resources/dcr/debating-safe-injecting-sites-in-vancouvers-inner-city-advocacy-conservatism-and-neoliberalism/https://harmreduction.eu/resources/dcr/designing-the-debate-assessing-the-role-of-design-practices-in-safe-injection-sites/https://harmreduction.eu/resources/dcr/do-supervised-injecting-facilities-attract-higher-risk-injection-drug-users/https://harmreduction.eu/resources/dcr/does-evidence-support-supervised-injection-sites/https://harmreduction.eu/resources/dcr/estimated-drug-overdose-deaths-averted-by-north-americas-first-medically-supervised-safer-injection-facility/https://harmreduction.eu/resources/dcr/evaluation-of-a-fentanyl-drug-checking-service-for-clients-of-a-supervised-injection-facility-vancouver-canada/https://harmreduction.eu/resources/dcr/community-house/https://harmreduction.eu/resources/dcr/examining-the-potential-role-of-a-supervised-injection-facility-in-saskatoon-saskatchewan-to-avert-hiv-among-people-who-inject-drugs/https://harmreduction.eu/resources/dcr/expanding-supervised-injection-facilities-across-canada-lessons-from-the-vancouver-experience/https://harmreduction.eu/resources/dcr/faq-supervised-consumption-services-at-sheldom-m-chumir-health-centre/https://harmreduction.eu/resources/dcr/fentanyl-self-testing-outside-supervised-injection-settings-to-prevent-opioid-overdose-do-we-know-enough-to-promote-it/https://harmreduction.eu/resources/dcr/findings-and-analysis-for-overdose-prevention-society/https://harmreduction.eu/resources/dcr/from-risky-places-to-safe-spaces-re-assembling-spaces-and-places-in-vancouvers-downtown-eastside/https://harmreduction.eu/resources/dcr/gendered-violence-overdose-prevention-sites-a-rapid-ethnographic-study-during-an-overdose-epidemic-in-vancouver-canada/https://harmreduction.eu/resources/dcr/hamilton-supervised-injection-site-needs-assessment-feasibility-study/https://harmreduction.eu/resources/dcr/harm-reduction-nursing-practice-the-dr-peter-centre-supervised-injection-project/https://harmreduction.eu/resources/dcr/help-me-fix-the-provision-of-injection-assistance-at-an-unsanctioned-overdose-prevention-site-in-toronto-canada/https://harmreduction.eu/resources/dcr/highs-and-lows-an-interrupted-time-series-evaluation-of-the-impact-of-north-americas-only-supervised-injection-facility-on-crime/https://harmreduction.eu/resources/dcr/housing-overdose-prevention-site-manual/https://harmreduction.eu/resources/dcr/impact-a-socio-economic-review-of-supervised-consumption-sites-in-alberta/https://harmreduction.eu/resources/dcr/impact-of-a-medically-supervised-safer-injecting-facility-on-drug-dealing-and-other-drug-related-crime/https://harmreduction.eu/resources/dcr/impact-of-a-medically-supervised-safer-injection-facility-on-community-drug-use-patterns-a-before-and-after-study/https://harmreduction.eu/resources/dcr/impact-of-supervised-drug-consumption-services-on-access-to-and-engagement-with-care-at-a-palliative-and-supportive-care-facility-for-people-living-with-hivaids-a-qualitative-study/https://harmreduction.eu/resources/dcr/implementation-contexts-and-the-impact-of-policing-on-access-to-supervised-consumption-services-in-toronto-canada-a-qualitative-comparative-analysis/https://harmreduction.eu/resources/dcr/increasing-public-support-for-supervised-injection-facilities-in-ontario-canada/https://harmreduction.eu/resources/dcr/injection-drug-use-cessation-and-use-of-north-americas-first-medically-supervised-safer-injecting-facility/https://harmreduction.eu/resources/dcr/is-vancouver-canadas-supervised-injection-facility-cost-saving/https://harmreduction.eu/resources/dcr/its-our-safe-sanctuary-experiences-of-using-an-unsanctioned-overdose-prevention-site-in-toronto-ontario/https://harmreduction.eu/resources/dcr/its-too-much-im-getting-really-tired-of-it-overdose-response-and-structural-vulnerabilities-among-harm-reduction-workers-in-community-settings/https://harmreduction.eu/resources/dcr/lessons-learned-from-supervised-consumption-and-overdose-prevention-sites-in-canada/https://harmreduction.eu/resources/dcr/losing-the-uphill-battle-emergent-harm-reduction-interventions-and-barriers-during-the-opioid-overdose-crisis-in-canada/https://harmreduction.eu/resources/dcr/methodology-for-evaluating-insite-canadas-first-medically-supervised-safer-injection-facility-for-injection-drug-users/https://harmreduction.eu/resources/dcr/mobile-supervised-consumption-services-in-rural-british-columbia-lessons-learned/https://harmreduction.eu/resources/dcr/modelling-the-combined-impact-of-interventions-in-averting-deaths-during-a-syntheticopioid-overdose-epidemic/https://harmreduction.eu/resources/dcr/negotiating-space-drug-use-in-emergency-shelters-with-peer-witness-injection-programs-within-the-context-of-an-overdose-crisis-a-qualitative-study/https://harmreduction.eu/resources/dcr/non-fatal-overdose-among-a-cohort-of-active-injection-drug-users-recruited-from-a-supervised-injection-facility/https://harmreduction.eu/resources/dcr/nurse-delivered-safer-injection-education-among-a-cohort-of-injection-drug-users-evidence-from-the-evaluation-of-vancouvers-supervised-injection-facility/https://harmreduction.eu/resources/dcr/observed-consumption-services/https://harmreduction.eu/resources/dcr/ontario-integrated-supervised-injection-services-feasibility-study-report-london/https://harmreduction.eu/resources/dcr/opening-canadas-first-health-canada-approved-supervised-consumption-sites/https://harmreduction.eu/resources/dcr/overdose-prevention-site-manual/https://harmreduction.eu/resources/dcr/overdose-prevention-society-year-end-report-2018/https://harmreduction.eu/resources/dcr/overdue-for-a-change-scaling-up-supervised-consumption-services-in-canada/https://harmreduction.eu/resources/dcr/peer-worker-involvement-in-low-threshold-supervised-consumption-facilitiesin-the-context-of-an-overdose-epidemic-in-vancouver-canada/https://harmreduction.eu/resources/dcr/police-and-public-health-partnerships-evidence-from-the-evaluation-of-vancouvers-supervised-injection-facility/https://harmreduction.eu/resources/dcr/police-perceptions-of-supervised-consumption-sites-scss-a-qualitative-study/https://harmreduction.eu/resources/dcr/policing-space-in-the-overdose-crisis-a-rapid-ethnographic-study-of-the-impact-of-law-enforcement-practices-on-the-effectiveness-of-overdose-prevention-sites/https://harmreduction.eu/resources/dcr/potential-community-and-public-health-impacts-of-medically-supervised-safer-smoking-facilities-for-crack-cocaine-users/https://harmreduction.eu/resources/dcr/potential-uptake-and-correlates-of-willingness-to-use-a-supervised-smoking-facility-for-noninjection-illicit-drug-use/https://harmreduction.eu/resources/dcr/prospects-for-scaling-up-supervised-injection-facilities-in-canada-the-role-of-evidence-in-legal-and-political-decision-making/https://harmreduction.eu/resources/dcr/public-injecting-among-people-who-inject-drugs-in-a-mid-sized-canadian-city/https://harmreduction.eu/resources/dcr/public-opinion-towards-supervised-injection-facilities-and-heroin-assisted-treatment-in-ontario-canada/https://harmreduction.eu/resources/dcr/public-opinions-about-supervised-smoking-facilities-for-crack-cocaine-and-other-stimulants/https://harmreduction.eu/resources/dcr/rapid-response-service-effectiveness-of-supervised-injection-services/https://harmreduction.eu/resources/dcr/rationale-for-evaluating-north-americas-first-medically-supervised-safer-injecting-facility/https://harmreduction.eu/resources/dcr/recommendations-from-the-toronto-residents-reference-panel-on-supervised-injection-services/https://harmreduction.eu/resources/dcr/reduction-in-overdose-mortality-after-the-opening-of-north-americas-first-medically-supervised-safer-injecting-facility/https://harmreduction.eu/resources/dcr/rigidity-dyskinesia-and-other-atypical-overdose-presentations-observed-at-a-supervised-injection-site-vancouver-canada/https://harmreduction.eu/resources/dcr/risk-creating-and-risk-reducing-community-perceptions-of-supervised-consumption-facilities-for-illicit-drug-use/https://harmreduction.eu/resources/dcr/safer-injecting-education-for-hiv-prevention-within-a-medically-supervised-safer-injecting-facility/https://harmreduction.eu/resources/dcr/safer-injection-facilities-in-north-america-their-place-in-public-policy-and-health-initiatives/https://harmreduction.eu/resources/dcr/safer-injection-facility-use-and-syringe-sharing-in-injection-drug-users/https://harmreduction.eu/resources/dcr/safer-washrooms-for-people-who-use-drugs-overdose-prevention-response-in-washrooms-recommendations-for-service-providers-version-3/https://harmreduction.eu/resources/dcr/saving-lives-changing-lives-summary-report-on-the-findings-from-an-evaluation-of-londons-temporary-overdose-prevention-site-tops-ontario/https://harmreduction.eu/resources/dcr/summary-of-findings-from-the-evaluation-of-a-pilot-medically-supervised-safer-injecting-facility/https://harmreduction.eu/resources/dcr/supervised-consumption-facilities-community-consultation-london-ontario/https://harmreduction.eu/resources/dcr/supervised-consumption-a-report-to-the-community-of-medicine-hat/https://harmreduction.eu/resources/dcr/supervised-inhalation-is-an-important-part-of-supervised-consumption-services/https://harmreduction.eu/resources/dcr/supervised-injection-facilities-in-canada-past-present-and-future/https://harmreduction.eu/resources/dcr/supervised-injection-facility-use-and-all-cause-mortality-among-people-who-inject-drugs-in-vancouver-canada-a-cohort-study/https://harmreduction.eu/resources/dcr/supervised-injection-facility-use-and-exposure-to-violence-among-a-cohort-of-people-who-inject-drugs-a-gender-based-analysis/https://harmreduction.eu/resources/dcr/supervised-injection-facility-utilization-patterns-a-prospective-cohort-study-in-vancouver-canada/https://harmreduction.eu/resources/dcr/supervised-injection-sites-a-position-paper-by-ontarios-police-leaders/https://harmreduction.eu/resources/dcr/support-of-supervised-injection-facilities-by-emergency-physicians-in-canada/https://harmreduction.eu/resources/dcr/thats-a-double-edged-sword-exploring-the-integration-of-supervised-consumption-services-within-community-health-centres-in-toronto-canada/https://harmreduction.eu/resources/dcr/the-canadian-governments-treatment-of-scientific-process-and-evidence-inside-the-evaluation-of-north-americas-first-supervised-injecting-facility/https://harmreduction.eu/resources/dcr/country-mission-finland-hiv-sexually-transmitted-infections-and-hepatitis-b-and-c/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-civil-society-monitoring-of-harm-reduction-in-europe-2019-data-report/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-comparing-times-spaces-and-actors-in-issues-of-social-acceptability-in-french-public-debate/https://harmreduction.eu/resources/dcr/enjoying-the-kick-locating-pleasure-within-the-drug-consumption-room/https://harmreduction.eu/resources/dcr/faq-supervised-injecting-facilities/https://harmreduction.eu/resources/dcr/feasibility-study-on-drug-consumption-rooms-in-belgium-etude-de-faisabilite-de-salles-de-consommation-a-moindre-risque-en-belgique/https://harmreduction.eu/resources/dcr/interview-with-odysseas-the-first-drug-consumption-room-created-in-greece/https://harmreduction.eu/resources/dcr/jeudi-de-lhemicycle-compte-rendu-de-la-matinee-detude-salle-de-consommation-a-moindre-risque-un-dispositif-utile-souhaitable-et-prioritaire-a-quand-a-bruxelles/https://harmreduction.eu/resources/dcr/louverture-de-salles-de-consommation-a-moindre-risque-une-affaire-dethique/https://harmreduction.eu/resources/dcr/le-stanze-del-consumo-evidenze-scientifiche-e-prove-di-efficacia-nella-documentazione-di-fuoriluogo/https://harmreduction.eu/resources/dcr/mobile-safe-injecting-facilities-in-barcelona-and-berlin/https://harmreduction.eu/resources/dcr/odysseas-supervised-use-of-drugs-versus-bureaucracy-in-greece/https://harmreduction.eu/resources/dcr/salle-de-consommation-a-moindre-risque-les-generalistes-majoritairement-favorables-a-lexperimentation/https://harmreduction.eu/resources/dcr/salle-de-shoot-les-salles-dinjection-supervisee-a-lheure-du-debat-francais/https://harmreduction.eu/resources/dcr/a-critical-evaluation-of-the-effects-of-safe-injection-facilities/https://harmreduction.eu/resources/dcr/a-critical-review-of-the-effectiveness-of-safe-injection-facilities-as-a-harm-reduction-strategy/https://harmreduction.eu/resources/dcr/an-overview-of-drug-consumption-rooms/https://harmreduction.eu/resources/dcr/appendix-b-guidelines-for-the-operation-and-use-of-consumption-rooms/https://harmreduction.eu/resources/dcr/commentary-on-pinkerton-2010-drug-consumption-roomstime-to-accept-their-worth/https://harmreduction.eu/resources/dcr/dcrs-adress/https://harmreduction.eu/resources/dcr/design-considerations-for-supervised-consumption-facilities-scfs-preferences-for-facilities-where-people-can-inject-and-smoke-drugs/https://harmreduction.eu/resources/dcr/document-3-comparison-of-three-supervised-consumption-service-scs-models/https://harmreduction.eu/resources/dcr/drug-consumption-facilities-an-update-since-2000/https://harmreduction.eu/resources/dcr/drug-consumption-rooms/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-dcrs-as-a-setting-to-address-hepatitis-c-findings-from-an-international-online-survey/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-literature-review/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-evidence-and-practice/https://harmreduction.eu/resources/dcr/drug-use-risk-and-urban-order-examining-supervised-injection-sites-siss-as-governmentality/https://harmreduction.eu/resources/dcr/international-consensus-statement-on-the-role-of-nurses-in-supervised-consumption-sites/https://harmreduction.eu/resources/dcr/konsumraume/https://harmreduction.eu/resources/dcr/legislating-for-health-and-human-rights-model-law-on-drug-use-and-hivaids-supervised-drug-consumption-facilities/https://harmreduction.eu/resources/dcr/making-the-case-for-supervised-injection-services/https://harmreduction.eu/resources/dcr/mobilizing-drug-consumption-rooms-inter-place-networks-and-harm-reduction-drug-policy/https://harmreduction.eu/resources/dcr/online-census-of-drug-consumption-rooms-dcrs-as-a-setting-to-address-hcv-current-practice-and-future-capacity/https://harmreduction.eu/resources/dcr/overview-of-international-literature-supervised-injecting-facilities-drug-consumption-rooms/https://harmreduction.eu/resources/dcr/public-health-and-public-order-outcomes-associated-with-supervised-drug-consumption-facilities-a-systematic-review/https://harmreduction.eu/resources/dcr/retracted-the-impact-of-medically-supervised-injection-centres-on-drug-related-harms-a-meta-analysis/https://harmreduction.eu/resources/dcr/salles-de-consommation-a-moindre-risque-les-preuves-et-la-pratique/https://harmreduction.eu/resources/dcr/scientific-and-programmatic-implications-of-safer-injection-facilities-for-persons-who-inject-drugs-illicitly/https://harmreduction.eu/resources/dcr/supervised-consumption-sites-a-nuanced-assessment-of-the-causal-evidence/https://harmreduction.eu/resources/dcr/supervised-drug-consumption-rooms/https://harmreduction.eu/resources/dcr/supervised-injecting-facilities-annotated-bibliography/https://harmreduction.eu/resources/dcr/supervised-injecting-facilities-what-the-literature-tells-us/https://harmreduction.eu/resources/dcr/supervised-injection-facilities-and-international-law/https://harmreduction.eu/resources/dcr/supervised-injection-services-what-has-been-demonstrated-a-systematic-literature-review/https://harmreduction.eu/resources/dcr/supervised-injection-sites-injection-drug-use-a-bibliography/https://harmreduction.eu/resources/dcr/survey-of-drug-consumption-rooms-service-delivery-and-perceived-public-health-and-amenity-impact/https://harmreduction.eu/resources/dcr/the-global-health-and-equity-imperative-for-safe-consumption-facilities/https://harmreduction.eu/resources/dcr/thematic-information-drug-consumption-rooms-global-state-of-harm-reduction-2018-briefing/https://harmreduction.eu/resources/dcr/une-depolitisation-hygienique-les-lieux-dinjection-de-drogues-illicites-comme-strategie-de-reduction-des-mefaits/https://harmreduction.eu/resources/dcr/what-is-the-current-evidence-for-the-efficacy-of-drug-consumption-rooms/https://harmreduction.eu/resources/dcr/attitudes-towards-safe-consumption-sites-among-police-and-people-with-lived-experience-in-tijuana-mexico-initial-report-from-the-field/https://harmreduction.eu/resources/dcr/correlates-of-seeking-injection-assistance-among-injection-drug-users-in-tijuana-mexico-correlates-of-seeking-help-injecting-in-tijuana-mexico/https://harmreduction.eu/resources/dcr/shooting-gallery-attendance-among-idus-in-tijuana-and-ciudad-juarez-mexico-correlates-prevention-opportunities-and-the-role-of-the-environment/https://harmreduction.eu/resources/dcr/ethical-reflections-emerging-during-the-activity-of-a-low-threshold-facility-with-supervised-drug-consumption-room-in-geneva-switzerland/https://harmreduction.eu/resources/dcr/monitorage-de-la-consommation-de-substances-dans-les-centres-daccueil-bas-seuil-rapport-annuel-2017/https://harmreduction.eu/resources/dcr/an-investigation-into-the-feasibility-of-establishing-drug-consumption-rooms/https://harmreduction.eu/resources/dcr/drug-consumption-rooms-a-welsh-response/https://harmreduction.eu/resources/dcr/evidence-and-issues-concerning-drug-consumption-rooms/https://harmreduction.eu/resources/dcr/frequently-asked-questions-safer-drug-consumption-facilities-and-heroin-assisted-treatment/https://harmreduction.eu/resources/dcr/increased-risk-of-hiv-and-other-drug-related-harms-associated-with-injecting-in-public-places-national-bio-behavioural-survey-of-people-who-inject-drugs/https://harmreduction.eu/resources/dcr/room-for-improvement-how-drug-consumption-rooms-save-lives/https://harmreduction.eu/resources/dcr/similar-problems-divergent-responses-drug-consumption-room-policies-in-the-uk-and-germany/https://harmreduction.eu/resources/dcr/a-cost-benefit-analysis-of-a-potential-supervised-injection-facility-in-san-francisco-california-usa/https://harmreduction.eu/resources/dcr/acceptability-of-a-safer-injection-facility-among-injection-drug-users-in-san-francisco/https://harmreduction.eu/resources/dcr/addressing-the-nations-opioid-epidemic-lessons-from-an-unsanctioned-supervised-injection-site-in-the-us/https://harmreduction.eu/resources/dcr/another-senseless-death-the-case-for-supervised-injection-facilities/https://harmreduction.eu/resources/dcr/arguments-supporting-and-opposing-legalization-of-safe-consumption-sites-in-the-us/https://harmreduction.eu/resources/dcr/assessing-the-evidence-on-supervised-drug-consumption-sites/https://harmreduction.eu/resources/dcr/associations-between-perceived-illicit-fentanyl-use-and-infectious-disease-risks-among-people-who-inject-drugs/https://harmreduction.eu/resources/dcr/bringing-safer-consumption-spaces-to-the-united-states/https://harmreduction.eu/resources/dcr/comprehensive-user-engagement-sites-cues-in-philadelphia-a-constructive-proposal/https://harmreduction.eu/resources/dcr/considering-heroin-assisted-treatment-and-supervised-drug-consumption-sites-in-the-united-states/https://harmreduction.eu/resources/dcr/drug-use-in-business-bathrooms-an-exploratory-study-of-manager-encounters-in-new-york-city/https://harmreduction.eu/resources/dcr/establishing-sanctioned-safe-consumption-sites-in-the-united-states-five-jurisdictions-moving-the-policy-agenda-forward/https://harmreduction.eu/resources/dcr/establishment-of-a-pilot-medically-supervised-injection-facility-in-massachusetts/https://harmreduction.eu/resources/dcr/estimated-impact-of-supervised-injection-facilities-on-overdose-fatalities-and-healthcare-costs-in-new-york-city/https://harmreduction.eu/resources/dcr/faq-supervised-injection-facility/https://harmreduction.eu/resources/dcr/federalism-policy-learning-and-local-innovation-in-public-health-the-case-of-the-supervised-injection-facility/https://harmreduction.eu/resources/dcr/harnessing-the-language-of-overdose-prevention-to-advance-evidence-based-responses-to-the-opioid-crisis/https://harmreduction.eu/resources/dcr/language-matters-in-combating-the-opioid-epidemic-safe-consumption-sites-versus-overdose-prevention-sites/https://harmreduction.eu/resources/dcr/mitigating-the-heroin-crisis-in-baltimore-md-usa-a-cost-benefit-analysis-of-a-hypothetical-supervised-injection-facility/https://harmreduction.eu/resources/dcr/new-strategies-are-needed-to-stop-overdose-fatalities-the-case-for-supervised-injection-facilities/https://harmreduction.eu/resources/dcr/overdose-prevention-in-the-united-states-a-call-for-supervised-injection-sites/https://harmreduction.eu/resources/dcr/overdose-prevention-site-acceptability-among-residents-and-businesses-surrounding-a-proposed-site-in-philadelphia-usa/https://harmreduction.eu/resources/dcr/perceptions-about-supervised-injection-facilities-among-people-who-inject-drugs-in-philadelphia/https://harmreduction.eu/resources/dcr/perspectives-on-supervised-injection-facilities-among-service-industry-employees-in-new-york-city-a-qualitative-exploration/https://harmreduction.eu/resources/dcr/public-drug-use-in-eight-us-cities-health-risks-and-other-factors-associated-with-place-of-drug-use/https://harmreduction.eu/resources/dcr/public-support-for-safe-consumption-sites-and-syringe-services-programs-to-combat-the-opioid-epidemic/https://harmreduction.eu/resources/dcr/research-on-supervised-injection-facilities-a-review-of-the-literature/https://harmreduction.eu/resources/dcr/safe-and-unsafe-spaces-non-fatal-overdose-arrest-and-receptive-syringe-sharing-among-people-who-inject-drugs-in-public-and-semi-public-spaces-in-baltimore-city/https://harmreduction.eu/resources/dcr/safe-drug-consumption-spaces-implications-for-baltimore-city/https://harmreduction.eu/resources/dcr/safer-consumption-spaces-in-the-united-states-uniting-for-a-national-movement/https://harmreduction.eu/resources/dcr/supervised-consumption-facilities-review-of-the-evidence/https://harmreduction.eu/resources/dcr/supervised-injection-facilities-recommendations-for-action/https://harmreduction.eu/resources/dcr/supervised-injection-facilities-legal-and-policy-reforms/https://harmreduction.eu/resources/dcr/the-case-for-supervised-consumption-services/https://harmreduction.eu/resources/dcr/the-controlled-substances-act-and-safe-consumption-facilities/https://harmreduction.eu/resources/dcr/the-costs-and-benefits-of-a-supervised-use-site-in-denver-colorado/https://harmreduction.eu/resources/dcr/the-law-and-politics-of-safe-injection-facilities-in-the-united-states/https://harmreduction.eu/resources/dcr/the-mayors-task-force-to-combat-the-opioid-epidemic-in-philadelphia-final-report-recommendations/https://harmreduction.eu/resources/dcr/the-projected-costs-and-benefits-of-a-supervised-injection-facility-in-seattle-wa-usa/https://harmreduction.eu/resources/dcr/the-willingness-of-people-who-inject-drugs-in-boston-to-use-a-supervised-injection-facility/https://harmreduction.eu/resources/dcr/using-drugs-in-unsafe-spaces-impact-of-perceived-illegality-on-an-underground-supervised-injecting-facility-in-the-united-states/https://harmreduction.eu/resources/dcr/willingness-to-use-a-supervised-injection-facility-among-young-adults-who-use-prescription-opioids-non-medically-a-cross-sectional-study/https://harmreduction.eu/resources/dcr/willingness-to-use-safe-consumption-spaces-among-opioid-users-at-high-risk-of-fentanyl-overdose-in-baltimore-providence-and-boston/https://harmreduction.eu/resources/dcr/supervised-injection-facilities-and-other-supervised-consumption-sites-effectiveness-and-value/https://harmreduction.eu/resources/overdose-prevention/2022-01-02https://harmreduction.eu/resources/overdose-prevention/latest-update-on-drug-related-deaths-and-mortality-in-europe/https://harmreduction.eu/resources/overdose-prevention/naloxone-on-release/https://harmreduction.eu/resources/overdose-prevention/harm-reduction-coalition/https://harmreduction.eu/resources/overdose-prevention/cope-australia/https://harmreduction.eu/resources/overdose-prevention/understanding-the-risks-of-mixing-medications-street-drugs/https://harmreduction.eu/resources/overdose-prevention/ontario-harm-reduction-distribution-program-naloxone-program/https://harmreduction.eu/resources/overdose-prevention/project-lazarus/https://harmreduction.eu/resources/overdose-prevention/guide-to-developing-managing-overdose-prevention-take-home-naloxone-projects-harm-reduction-coalition/https://harmreduction.eu/resources/overdose-prevention/opioid-overdose-reversal-with-naloxone-narcan-evzio/https://harmreduction.eu/resources/overdose-prevention/the-chicago-recovery-alliance/https://harmreduction.eu/resources/overdose-prevention/naloxone-rescue-for-opioid-overdose/https://harmreduction.eu/resources/overdose-prevention/scotlands-take-home-naloxone-programme/https://harmreduction.eu/resources/overdose-prevention/naloxone-a-take-home-antidote-to-drug-overdose-that-saves-lives/https://harmreduction.eu/resources/overdose-prevention/naloxone-therapy-in-opioid-overdose-patients-intranasal-or-intravenous-a-randomized-clinical-trial/https://harmreduction.eu/resources/overdose-prevention/take-home-naloxone-program/https://harmreduction.eu/resources/overdose-prevention/opioid-overdose-prevention-programs-providing-naloxone-to-laypersons-united-states-2014/https://harmreduction.eu/resources/overdose-prevention/naloxone-overview-side-effects-dosage/https://harmreduction.eu/resources/overdose-prevention/fentanyl-safety/https://harmreduction.eu/resources/overdose-prevention/the-hse-naloxone-demonstration-project-update/https://harmreduction.eu/resources/overdose-prevention/how-to-use-naloxone/https://harmreduction.eu/resources/overdose-prevention/naloxone-the-welsh-experience/https://harmreduction.eu/resources/overdose-prevention/how-strong-is-the-evidence-for-benefit-from-take-home-naloxone/https://harmreduction.eu/resources/overdose-prevention/opioid-commission-needs-a-push-on-naloxone/https://harmreduction.eu/resources/overdose-prevention/what-is-naloxone/https://harmreduction.eu/resources/overdose-prevention/schweiz-allgemeiner-uberblick-definitionen-nebenwirkungen-etc/https://harmreduction.eu/resources/overdose-prevention/naloxon-im-rettungsdienst/https://harmreduction.eu/resources/overdose-prevention/fixpunkt/https://harmreduction.eu/resources/overdose-prevention/targin-oxycodonnaloxon/https://harmreduction.eu/resources/overdose-prevention/part-1-of-3-take-home-naloxone-the-scottish-experience/https://harmreduction.eu/resources/overdose-prevention/part-2-of-3-take-home-naloxone-the-scottish-experience/https://harmreduction.eu/resources/overdose-prevention/part-3-of-3-take-home-naloxone-the-scottish-experience/https://harmreduction.eu/resources/overdose-prevention/how-to-use-the-va-intramuscular-naloxone-kit/https://harmreduction.eu/resources/overdose-prevention/naloxone-nasal-spray-demonstration/https://harmreduction.eu/resources/overdose-prevention/making-naloxone-work/https://harmreduction.eu/resources/overdose-prevention/narcan-training-video/https://harmreduction.eu/resources/overdose-prevention/how-to-use-narcan-naloxone-hcl-nasal-spray/https://harmreduction.eu/resources/overdose-prevention/using-nasal-naloxone-to-reverse-opiate-overdose/https://harmreduction.eu/resources/overdose-prevention/scotlands-national-naloxone-programme-why-how-what-next/https://harmreduction.eu/resources/overdose-prevention/naloxone-is-childs-play/https://harmreduction.eu/resources/overdose-prevention/im-the-evidence-naloxone-works-uk/https://harmreduction.eu/resources/overdose-prevention/im-the-evidence-naloxone-works-lithuania/https://harmreduction.eu/resources/overdose-prevention/im-the-evidence-naloxone-works-italy/https://harmreduction.eu/resources/overdose-prevention/im-the-evidence-naloxone-works-france/https://harmreduction.eu/resources/overdose-prevention/im-the-evidence-naloxone-works-estonia/https://harmreduction.eu/resources/overdose-prevention/im-the-evidence-naloxone-works-denmark/https://harmreduction.eu/resources/overdose-prevention/metadon-podstawy/https://harmreduction.eu/resources/overdose-prevention/methadone-a-guide-for-providers/https://harmreduction.eu/resources/overdose-prevention/overdose-prevention-and-response-a-guide-for-people-who-use-drugs-and-harm-reduction-staff-in-eastern-europe-and-central-asia-by-matt-curtis-and-lydia-guterman/https://harmreduction.eu/resources/overdose-prevention/fact-sheet-preventiong-and-reducing-drug-overdoses/https://harmreduction.eu/resources/overdose-prevention/preventing-overdose-deaths-in-europe/https://harmreduction.eu/resources/overdose-prevention/increased-presence-of-fentanyl-in-cocaine-involved-fatal-overdoses-implications-for-prevention/https://harmreduction.eu/resources/overdose-prevention/women-who-inject-drugs-overlooked-yet-visable/https://harmreduction.eu/resources/overdose-prevention/perspectives-on-drugs-preventing-overdose-deaths-in-europe-emcdda-2018/https://harmreduction.eu/resources/overdose-prevention/naloxone-focus-report/https://harmreduction.eu/resources/overdose-prevention/european-research-on-risk-factors-for-overdose-drugnet-ireland-issue-49/https://harmreduction.eu/resources/overdose-prevention/drugscom/https://harmreduction.eu/resources/overdose-prevention/saving-lives-best-practice-guidance-on-the-provision-of-naloxone-for-people-who-might-experience-or-witness-an-opioid-overdose/https://harmreduction.eu/resources/overdose-prevention/nalxone-focus-report/https://harmreduction.eu/resources/overdose-prevention/overdose-prevention-status-quo-and-challenges/https://harmreduction.eu/resources/overdose-prevention/overdose-prevention-new-technology-based-solutions/https://harmreduction.eu/resources/overdose-prevention/evidence-based-strategiesfor-preventing-opioid-overdosewhats-working-in-the-united-statesan-introduction-for-public-heath-law-enforcementlocal-organizations-and-others-striving-to-serve-their-community/https://harmreduction.eu/resources/overdose-prevention/access-saves-lives-opioid-overdose-treatment/https://harmreduction.eu/resources/overdose-prevention/guidelines-naloxone-provision-upon-release-prison-and-other-custodial-settings/https://harmreduction.eu/resources/overdose-prevention/my-first-48-hours-out-visual-booklet/https://harmreduction.eu/resources/overdose-prevention/effect-of-intranasal-vs-intramuscular-naloxone-on-opioid-overdose-a-randomized-clinical-trial/https://harmreduction.eu/resources/outreach-work/2022-01-02https://harmreduction.eu/resources/outreach-work/street-support-assesment-report/https://harmreduction.eu/resources/outreach-work/street-support-european-report/https://harmreduction.eu/resources/outreach-work/street-support-national-report-germany/https://harmreduction.eu/resources/outreach-work/street-support-national-report-czech-republic/https://harmreduction.eu/resources/outreach-work/street-support-national-report-netherlands/https://harmreduction.eu/resources/outreach-work/street-support-national-report-ireland/https://harmreduction.eu/resources/outreach-work/street-support-national-report-spain/https://harmreduction.eu/resources/outreach-work/street-support-local-pilot-intervention-czech-republic/https://harmreduction.eu/resources/outreach-work/street-support-local-pilot-intervention-germany/https://harmreduction.eu/resources/outreach-work/street-support-local-pilot-intervention-ireland/https://harmreduction.eu/resources/outreach-work/street-support-local-pilot-intervention-spain/https://harmreduction.eu/resources/outreach-work/street-support-good-practice-collection/https://harmreduction.eu/resources/outreach-work/street-support-tool-box/https://harmreduction.eu/resources/needle-exchange/2022-01-02https://harmreduction.eu/resources/needle-exchange/prison-needle-and-syringe-programmes-pnsp/https://harmreduction.eu/resources/needle-exchange/needle-exchange-in-berlin-in-prison-and-in-society/https://harmreduction.eu/resources/needle-exchange/exercise-needle-sharing-and-drug-sharing/https://harmreduction.eu/resources/needle-exchange/health-outcomes-for-clients-of-needle-and-syringe-programs-in-prisons-a-systematic-review/https://harmreduction.eu/resources/other-hr-interventions/2022-01-03https://harmreduction.eu/resources/other-hr-interventions/civil-society-monitoring-of-harm-reduction-in-europe-2019/https://harmreduction.eu/resources/other-hr-interventions/1032users-about-omt-in-norway-a-user-to-user-survey-conducted-by-prolar/https://harmreduction.eu/resources/other-hr-interventions/le-present-ouvrage-est-une-aide-a-la-reflexion-pour-une-experimentation-de-ce-dispositif-de-reduction-des-risques/https://harmreduction.eu/resources/hbv-hcv/2022-01-03https://harmreduction.eu/resources/hbv-hcv/emcdda-harm-reduction-initiative/https://harmreduction.eu/resources/hbv-hcv/coffee-and-caffeine-are-associated-with-decreased-risk-ofadvanced-hepatic-fibrosis-among-patients-with-hepatitis-c/https://harmreduction.eu/resources/hbv-hcv/linoleic-acid-induced-acute-hepatitis-a-case-report-and-review-of-the-literature/https://harmreduction.eu/resources/hbv-hcv/fish-oil-rich-diet-promotes-hematopoiesis-and-altershematopoietic-niche/https://harmreduction.eu/resources/hbv-hcv/a-brief-overview-of-liver-toxic-herbs/https://harmreduction.eu/resources/hbv-hcv/association-between-psychological-distress-and-liver-diseasemortality-a-meta-analysis-of-individual-study-participants/https://harmreduction.eu/resources/hbv-hcv/on-stress-and-the-liver-a-chicken-and-egg-conundrum/https://harmreduction.eu/resources/hbv-hcv/tired-with-hep-c-avoid-these5-foods/https://harmreduction.eu/resources/hbv-hcv/top-10-sources-of-proteinintake-for-hepatitis-c/https://harmreduction.eu/resources/hbv-hcv/traditional-chinese-medicine-and-hcv/https://harmreduction.eu/resources/hbv-hcv/complementary-and-alternative-therapies-in-the-treatment-of-chronic-hepatitis-c-a-systematic-review/https://harmreduction.eu/resources/hbv-hcv/how-does-coffee-prevent-liver-fibrosis-biological-plausibility-for-recent-epidemiological-observations/https://harmreduction.eu/resources/hbv-hcv/hepatitis-c-epidemiology-and-review-of-complementaryalternative-medicine-treatments/https://harmreduction.eu/resources/hbv-hcv/hepatitis-c-focus-on-dietary-supplements/https://harmreduction.eu/resources/hbv-hcv/marijuana-does-not-accelerate-liver-disease-in-hivhcv-coinfection/https://harmreduction.eu/resources/hbv-hcv/increased-intake-of-vegetables-but-not-fruit-reduces-risk-for-hepatocellularcarcinoma-a-meta-analysis/https://harmreduction.eu/resources/hbv-hcv/the-top-three-alternative-treatments-for-hepatitis-c/https://harmreduction.eu/resources/hbv-hcv/decline-in-incidence-of-hiv-and-hepatitis-c-virusinfection-among-injecting-drug-users-in-amsterdamevidence-for-harm-reduction/https://harmreduction.eu/resources/hbv-hcv/global-regional-and-national-incidence-prevalence-and-years-lived-with-disability-for-301-acute-and-chronic-diseases-and-injuries-in-188-countries-1990-2013-a-systematic-analysis-for-the-global-burden-of-disease-study-2013/https://harmreduction.eu/resources/hbv-hcv/estimates-on-hcv-disease-burden-worldwide-filling-the-gaps/https://harmreduction.eu/resources/hbv-hcv/dietary-carbohydrate-intake-and-mortality-a-prospective-cohort-study-and-meta-analysis/https://harmreduction.eu/resources/hbv-hcv/talking-about-hepatitis-c-faqs-from-young-adults-who-inject-drugs/https://harmreduction.eu/resources/hbv-hcv/harm-reduction-based-and-peer-supported-hepatitis-c-treatment-for-people-who-inject-drugs-in-georgia-tamar-kikvidze-et-al/https://harmreduction.eu/resources/hbv-hcv/protective-effect-of-coffee-consumption-on-all-cause-mortality-of-french-hiv-hcv-co-infected-patients-carriere-mp-et-al/https://harmreduction.eu/resources/hbv-hcv/improving-engagement-with-healthcare-in-hepatitis-c-a-randomised-controlled-trial-of-a-peer-support-intervention-r-stagg-et-al/https://harmreduction.eu/resources/hbv-hcv/global-regional-and-country-level-coverage-of-interventions-to-prevent-and-manage-hiv-and-hepatitis-c-among-people-who-inject-drugs-a-systematic-review-larney-et-al/https://harmreduction.eu/resources/hbv-hcv/understanding-and-addressing-hepatitis-c-virus-reinfection-among-men-who-have-sex-with-men-martin-et-al/https://harmreduction.eu/resources/hbv-hcv/training-manual-for-treatment-advocates-hepatitis-c-virus-coinfection-with-hiv-annette-gaudino-bryn-gay-and-tim-horn/https://harmreduction.eu/resources/hbv-hcv/liver-or-die-hcv-training-for-peer-workers/https://harmreduction.eu/resources/hbv-hcv/hepatitis-b-and-c-testing-why-who-how/https://harmreduction.eu/resources/hbv-hcv/hepatitis-c-testing-in-the-community/https://harmreduction.eu/resources/hbv-hcv/online-peer-support-manual/https://harmreduction.eu/resources/hbv-hcv/point-of-care-testing-poct-in-molecular-diagnostics-performance-evaluation-of-genexpert-hcv-rna-test-in-diagnosing-and-monitoring-of-hcv-infection/https://harmreduction.eu/resources/hbv-hcv/strategies-to-reduce-hepatitis-c-virus-reinfection-in-people-who-inject-drugs-martinello-et-al/https://harmreduction.eu/resources/hbv-hcv/model-projections-on-the-impact-of-hcv-treatment-in-the-prevention-of-hcv-transmission-among-people-who-inject-drugs-in-europe-fraser-h-et-al/https://harmreduction.eu/resources/hbv-hcv/recovery-of-infectious-hepatitis-c-virus-from-injection-paraphernalia-implications-for-prevention-programs-serving-people-who-inject-drugs-heimer-et-al/https://harmreduction.eu/resources/hbv-hcv/m-hellard-et-al-achieving-hepatitis-c-elimination-in-europe-to-treatment-scale-up-and-beyond/https://harmreduction.eu/resources/hbv-hcv/micro-elimination-a-path-to-global-elimination-of-hepatitis-c/https://harmreduction.eu/resources/hbv-hcv/legal-barriers-for-providing-hcv-community-testing-in-europe/https://harmreduction.eu/resources/hbv-hcv/hcv-in-integrated-harm-reduction-services/https://harmreduction.eu/resources/hbv-hcv/hepatitis-c-community-summit-2018/https://harmreduction.eu/resources/hbv-hcv/hcv-community-testing/https://harmreduction.eu/resources/hbv-hcv/hepatitis-c-virus-reinfection-after-successful-treatment-with-direct-acting-antiviral-therapy-in-a-large-population-based-cohort/https://harmreduction.eu/resources/hbv-hcv/direct-acting-antiviral-based-treatment-of-hepatitis-c-virus-infection-among-people-who-inject-drugs-in-georgia-a-prospective-cohort-study/https://harmreduction.eu/resources/hbv-hcv/scaling-up-prevention-and-treatment-towards-the-elimination-of-hepatitis-c-a-global-mathematical-model-alastair-heffernan-et-al/https://harmreduction.eu/resources/hbv-hcv/achieving-hepatitis-c-elimination-in-europe-to-treatment-scale-up-and-beyond-m-hellard-et-al/https://harmreduction.eu/resources/hbv-hcv/direct-acting-antiviral-treatment-for-hepatitis-c-among-people-who-use-or-inject-drugs-a-systematic-review-and-meta-analysis/https://harmreduction.eu/resources/hbv-hcv/protective-effect-of-coffee-consumption-on-all-cause-mortality-of-french-hiv-hcv-co-infected-patients-maria-p-carrieri-et-al/https://harmreduction.eu/resources/hbv-hcv/hepatitis-c-virus-diagnosis-and-the-holy-grail/https://harmreduction.eu/resources/hbv-hcv/easl-commission-on-liver-diseases-in-europe-overcoming-unmet-needs-stigma-and-inequities/https://harmreduction.eu/resources/hbv-hcv/has-access-to-hepatitis-c-virus-therapy-changed-for-patients-with-mental-health-or-substance-use-disorders-in-the-direct-acting-antiviral-period-jain-et-al/https://harmreduction.eu/resources/hbv-hcv/action-plan-for-the-health-sector-response-to-viral-hepatitis-in-the-who-european-region/https://harmreduction.eu/resources/hbv-hcv/global-regional-and-country-level-coverage-of-interventions-to-prevent-and-manage-hiv-and-hepatitis-c-among-people-who-inject-drugs-a-systematic-review/https://harmreduction.eu/resources/hbv-hcv/achieving-hepatitis-c-elimination-in-europe-to-treatment-scale-up-and-beyond/https://harmreduction.eu/resources/hbv-hcv/increases-in-acute-hepatitis-c-virus-infection-related-to-a-growing-opioid-epidemic-and-associated-injection-drug-use-united-states-2004-to-2014-zibbell-et-al/https://harmreduction.eu/resources/hbv-hcv/interim-impact-evaluation-of-the-hepatitis-c-virus-elimination-program-in-georgia/https://harmreduction.eu/resources/hbv-hcv/progress-report-on-hiv-viral-hepatitis-and-sexually-transmitted-infections-2019-accountability-for-the-global-health-sector-strategies-20162021/https://harmreduction.eu/resources/hbv-hcv/hepatitis-c-new-models-of-care-for-drug-services/https://harmreduction.eu/resources/hbv-hcv/who-hepatitis-c-fact-sheet/https://harmreduction.eu/resources/hbv-hcv/treatment-action-group-pipeline-report-hcv-diagnostics/https://harmreduction.eu/resources/hbv-hcv/treatment-action-group-pipeline-report-hcv-treatments/https://harmreduction.eu/resources/hbv-hcv/treatment-action-group-hepatitis-fact-sheets/https://harmreduction.eu/resources/hbv-hcv/hep-c-coalition-fact-sheets-for-compreensive-hcv-services-for-people-who-use-drugs/https://harmreduction.eu/resources/hbv-hcv/easl-recommendations-on-treatment-of-hepatitis-c-2018/https://harmreduction.eu/resources/hbv-hcv/ecdc-technical-report-hepatitis-b-and-c-testing-activities-needs-and-priorities-in-the-eueea/https://harmreduction.eu/resources/hbv-hcv/public-health-guidance-on-hiv-hbv-and-hcv-testing-in-the-eueea/https://harmreduction.eu/resources/hbv-hcv/university-of-liverpool-hcv-medication-interaction-website/https://harmreduction.eu/resources/hbv-hcv/monitoring-of-hcv-testing-in-low-threshold-drug-services-heike-zurhold/https://harmreduction.eu/resources/hbv-hcv/drug-consumption-rooms-evidence-and-practice/https://harmreduction.eu/resources/hbv-hcv/data-collection-protocal-for-specialist-harm-reduction-agencies/https://harmreduction.eu/resources/hbv-hcv/evaluation-guide/https://harmreduction.eu/resources/hbv-hcv/monitoring-the-responses-tohepatitis-b-and-c-epidemicsin-the-eueea-member-states2019/https://harmreduction.eu/resources/hbv-hcv/beyond-clinical-outcomes-the-social-andhealthcare-system-implications-of-hepatitisc-treatment/https://harmreduction.eu/resources/hbv-hcv/easl-policy-statementdrug-use-and-the-global-hepatitis-c-elimination-goal/https://harmreduction.eu/resources/hbv-hcv/improving-testing-rates-blood-borne-viruses-prisons-and-other-secure-settings/https://harmreduction.eu/resources/hbv-hcv/training-manual-hiv-and-hcv-rapid-testing-low-threshold-settings-pwud/https://harmreduction.eu/resources/hivaids/2022-01-03https://harmreduction.eu/resources/hivaids/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/https://harmreduction.eu/resources/hivaids/exploring-the-facts-about-hivaids/https://harmreduction.eu/resources/hivaids/who-guide-for-planning-introducing-and-scaling-up-hiv-self-testing/https://harmreduction.eu/resources/hivaids/university-of-liverpool-hiv-medication-interaction-website/https://harmreduction.eu/resources/hivaids/flew-project-free-live-well-hiv-prison/https://harmreduction.eu/resources/covid-19/2022-01-03https://harmreduction.eu/resources/covid-19/infographics-to-support-smokers-quit-smoking-in-the-times-of-covid-19/https://harmreduction.eu/resources/covid-19/emcdda-trendspotter-briefing-impact-of-covid-19-on-drug-services-and-help-seeking-in-europe/https://harmreduction.eu/resources/covid-19/drug-scene-people-who-use-drugs-and-addictological-services-during-the-covid-19-emergency-in-the-czech-republic-1/https://harmreduction.eu/resources/covid-19/drug-scene-people-who-use-drugs-and-addictological-services-during-the-covid-19-emergency-in-the-czech-republic-2/https://harmreduction.eu/resources/covid-19/interruption-and-innovation-the-impact-of-policy-measures-during-the-covid-19-pandemic-on-key-and-vulnerable-populations-for-hiv-tuberculosis-and-viral-hepatitis-in-eastern-europe-and-central-asia/https://harmreduction.eu/resources/covid-19/nlo-briefing-papercovid-19-in-marginalised-groupschallenges-actions-and-voices/https://harmreduction.eu/resources/covid-19/voices-of-frontline-workers-harm-reduction-responses-in-the-european-region-during-the-covid-19-pandemic/https://harmreduction.eu/resources/covid-19/lessons-from-covid-19to-reshape-a-sustainable-response-to-hiv-tband-hcv-among-inadequately-served-populationsin-the-countries-of-eastern-europe-and-central-asia/https://harmreduction.eu/resources/covid-19/the-impact-of-covid-19-on-civil-society-organisations-in-eastern-europe-and-central-asia/https://harmreduction.eu/resources/covid-19/updates-and-guidance-on-covid-19-pandemic/https://harmreduction.eu/resources/covid-19/situation-update-for-the-eueea-and-the-uk/https://harmreduction.eu/resources/covid-19/eu-coronavirus-response-website/https://harmreduction.eu/resources/covid-19/how-harm-reducers-cope-with-the-covid-19-pandemic-in-europe/https://harmreduction.eu/resources/covid-19/8-corona-tips-voor-mensen-die-drugs-gebruiken/https://harmreduction.eu/resources/covid-19/guidance-on-contingency-planning-for-people-who-use-drugs-and-covid-19-v10/https://harmreduction.eu/resources/covid-19/consumo-de-sustancias-psycoactivas-en-cuarentena/https://harmreduction.eu/resources/covid-19/covid-19-protocols/https://harmreduction.eu/resources/covid-19/flyer-back/https://harmreduction.eu/resources/covid-19/party-drugs-in-the-time-of-coronavirus/https://harmreduction.eu/resources/covid-19/covid-19-guidance-clinicians-amp-opioid-treatment-programs/https://harmreduction.eu/resources/covid-19/covid-19-guidance-patients-engaged-in-substance-use-treatment/https://harmreduction.eu/resources/covid-19/guidance-for-people-who-use-substances-on-covid-19/https://harmreduction.eu/resources/covid-19/an-open-letter-on-covid-19-and-pwud/https://harmreduction.eu/resources/covid-19/guidance-on-preparedness-prevention-amp-control-of-covid-19-in-prisons-amp-places-of-detention/https://harmreduction.eu/resources/covid-19/drogas-y-covid-19/https://harmreduction.eu/resources/covid-19/harm-reduction-for-people-who-use-drugs/https://harmreduction.eu/resources/covid-19/basic-protective-measures-against-the-new-coronavirus/https://harmreduction.eu/resources/covid-19/covid-19-8211-guidance-for-people-who-use-drugs-amp-harm-reduction-programs/https://harmreduction.eu/resources/covid-19/coronavirus-8211-general-hygiene-harm-reduction-tips/https://harmreduction.eu/resources/covid-19/rights-in-the-time-of-covid-19-lessons-from-hiv-for-an-effective-community-led-response/https://harmreduction.eu/resources/covid-19/harm-reduction-must-go-on/https://harmreduction.eu/resources/covid-19/human-rights-dimensions-of-covid-19-response/https://harmreduction.eu/resources/covid-19/prisoners-rights-matter-statement/https://harmreduction.eu/resources/covid-19/covid-19-sex-workers-need-immediate-financial-support-and-protection/https://harmreduction.eu/resources/covid-19/coronavirus-healthcare-and-human-rights-of-people-in-prison/https://harmreduction.eu/resources/covid-19/podcast-emergency-measures/https://harmreduction.eu/resources/covid-19/webinar-series-on-covid-19-and-substance-dependence/https://harmreduction.eu/resources/covid-19/webinar-medications-for-opioid-use-disorder-and-the-covid-19/https://harmreduction.eu/resources/covid-19/webinar-harm-reduction-covid-19-and-people-who-use-drugs/https://harmreduction.eu/resources/covid-19/podcast-how-to-handle-coronavirus-anxiety-special-editionspan/https://harmreduction.eu/resources/covid-19/coronavirus-wisdom-from-a-social-justice-len/https://harmreduction.eu/resources/covid-19/preventing-covid-19-outbreak-in-prisons-a-challenging-but-essential-task-for-authorities/https://harmreduction.eu/resources/covid-19/covid-19-and-people-who-use-drugs-the-pompidou-groups-response-platform/https://harmreduction.eu/resources/covid-19/call-to-action-in-response-to-covid-19/https://harmreduction.eu/resources/covid-19/call-to-action-in-response-to-covid-19-russian/https://harmreduction.eu/resources/covid-19/impact-covid-19-drug-markets-use-harms-and-drug-services-community-and-prisons-results-emcdda-trendspotter-study-april-2021/https://harmreduction.eu/resources/other-diseases/https://harmreduction.eu/resources/opioids/https://harmreduction.eu/resources/stimulants/2022-01-03https://harmreduction.eu/resources/stimulants/speed-limits-harm-reduction-for-people-who-use-stimulants/https://harmreduction.eu/resources/stimulants/treatment-stimulant-use-disorders-current-practices-and-promising-perspectives-discussion-paper/https://harmreduction.eu/resources/stimulants/hiv-prevention-treatment-care-and-support-people-who-use-stimulant-drugs-technical-guide/https://harmreduction.eu/resources/stimulants/chemsex-and-harm-reduction-gay-men-and-other-men-who-have-sex-men/https://harmreduction.eu/resources/stimulants/report-violations-rights-men-who-have-sex-men-engaged-sex-work-and-chemsex-ukraine/https://harmreduction.eu/resources/stimulants/treatment-prevention-and-harm-reduction-interventions-different-forms-ats-use/https://harmreduction.eu/resources/new-drug-trends/https://harmreduction.eu/resources/alcohol/https://harmreduction.eu/resources/alcohol/alcohol-self-assessment-test/https://harmreduction.eu/resources/alcohol/no-level-of-alcohol-consumption-improves-health/https://harmreduction.eu/resources/nicotine/https://harmreduction.eu/resources/nicotine/role-cigarette-smoke-ace-2-protein-membrane-expression-bronchial-epithelial-cells/https://harmreduction.eu/resources/drug-policy/2022-01-03https://harmreduction.eu/resources/drug-policy/european-drug-report-2019/https://harmreduction.eu/resources/drug-policy/what-is-harm-reduction-drugreporters-just-say-know-series-episode-4/https://harmreduction.eu/resources/drug-policy/civil-society-involvement-harm-reduction-drug-policy-reflections-past-expectations-future/https://harmreduction.eu/resources/civil-society/2022-01-03https://harmreduction.eu/resources/civil-society/eu-civil-society-forum-on-drugs-briefing-paper-on-eu-drug-policy-the-action-plan-and-the-need-for-civil-society/https://harmreduction.eu/resources/civil-society/civil-society-involevement-in-drug-policy-a-road-map/https://harmreduction.eu/resources/civil-society/amsterdam-drug-scene-1975-2010/https://harmreduction.eu/resources/civil-society/model-ethical-funding-policy-to-help-civil-society-organisations/https://harmreduction.eu/resources/civil-society/case-study-report-on-local-civil-society-actions-challenges-in-implementing-the-eu-action-plan-on-drugs-at-the-national-level/https://harmreduction.eu/resources/civil-society/guidelines-and-recommendations-english/https://harmreduction.eu/resources/civil-society/guidelines-and-recommendations-italian/https://harmreduction.eu/resources/civil-society/guidelines-and-recommendations-swedish/https://harmreduction.eu/resources/civil-society/guidelines-and-recommendations-slovenian/https://harmreduction.eu/resources/civil-society/guidelines-and-recommendations-spanish/https://harmreduction.eu/resources/civil-society/guidelines-and-recommendations-hungarian/https://harmreduction.eu/resources/civil-society/harm-reduction-europe-framework-civil-society-led-monitoring/https://harmreduction.eu/resources/civil-society/civil-society-monitoring-hepatitis-c-response-related-who-2030-elimination-goals-35-european-countries/https://harmreduction.eu/resources/civil-society/civil-society-monitoring-harm-reduction-europe-2020/https://harmreduction.eu/resources/criminalization-and-stigma/https://harmreduction.eu/resources/other-policy-issues/https://harmreduction.eu/resources/other-policy-issues/beyond-clinical-outcomes-social-and-healthcare-system-implications-hepatitis-c-treatment/https://harmreduction.eu/resources/other-policy-issues/novel-health-systems-service-design-checklist-improve-healthcare-access-marginalised-underserved-communities-europe/https://harmreduction.eu/resources/pwid/2022-01-03https://harmreduction.eu/resources/pwid/we-are-still-obsessed-by-this-idea-of-abstinence-a-critical-analysis-of-uk-news-media-representations-of-proposals-to-introduce-drug-consumption-rooms-in-glasgow-uk/https://harmreduction.eu/resources/pwid/harm-reduction-service-delivery-people-who-use-drugs-during-public-health-emergency-examples-covid-19-pandemic-selected-countries/https://harmreduction.eu/resources/wwud/https://harmreduction.eu/resources/young-people/https://harmreduction.eu/resources/old-people/2022-01-03https://harmreduction.eu/resources/old-people/drugs-dont-have-age-limits-the-challenge-of-setting-age-restrictions-for-supervised-injection-facilities/https://harmreduction.eu/resources/old-people/betrad-better-treatment-of-aging-drug-users-best-practice-collection/https://harmreduction.eu/resources/old-people/better-treatment-of-aging-drug-users-tool-box/https://harmreduction.eu/resources/old-people/betrad-better-treatment-of-aging-drug-users-national-report-netherlands/https://harmreduction.eu/resources/homeless/2022-01-03https://harmreduction.eu/resources/homeless/clinical-guideline-for-homeless-and-vulnerably-housed-people-and-people-with-lived-homelessness-experience/https://harmreduction.eu/resources/homeless/guidance-for-substance-misuse-and-homelessness-services-v10/https://harmreduction.eu/resources/homeless/covid-19-staying-home-not-an-option-for-people-experiencing-homelessness-span/https://harmreduction.eu/resources/indigenous-populations/2022-01-03https://harmreduction.eu/resources/prisons/2022-01-03https://harmreduction.eu/resources/prisons/opioid-substitution-treatment-in-prison/https://harmreduction.eu/resources/prisons/condom-distribution-program-in-prison/https://harmreduction.eu/resources/prisons/harm-reduction-in-prison/https://harmreduction.eu/resources/prisons/integrated-care-models-for-people-who-inject-drugs/https://harmreduction.eu/resources/prisons/nalokson-po-wyjsciu-na-wolnosc/https://harmreduction.eu/resources/prisons/przewodnik-po-terapii-substytucyjnej-w-jednostkach-penitencjarnych/https://harmreduction.eu/resources/prisons/program-dystrybucji-prezerwatyw-w-jednostce-penitencjarnej/https://harmreduction.eu/resources/prisons/take-home-emergency-naloxone-to-prevent-heroin-overdose-deaths-after-prison-release-rationale-and-practicalities-for-the-n-alive-randomized-trial/https://harmreduction.eu/resources/prisons/jak-to-sie-robi-w-luksemburgu/https://harmreduction.eu/resources/prisons/ost-in-prison-republic-of-moldova/https://harmreduction.eu/resources/prisons/innovative-drug-treatment-programme-for-prisoners-in-moldova/https://harmreduction.eu/resources/prisons/penitentiary-system-in-denmark/https://harmreduction.eu/resources/prisons/drug-use-among-prisoners-and-treatment-for-drug-users-in-the-prison-setting/https://harmreduction.eu/resources/prisons/risk-of-contracting-hiv-in-prison-population/https://harmreduction.eu/resources/prisons/harm-reduction-in-prison-settings-in-luxembourg/https://harmreduction.eu/resources/prisons/12-naibolee-chasto-zadavaemykh-voprosov-o-gepatite-s/https://harmreduction.eu/resources/prisons/basic-ost-in-prison-presentation-and-group-work-exercise/https://harmreduction.eu/resources/prisons/boiling-injection-equipment/https://harmreduction.eu/resources/prisons/situatsii-svyazannye-s-upotrebleniem-narkotikov-v-tyurme-kogda-i-kak-sleduet-vmeshatsya/https://harmreduction.eu/resources/prisons/ctandarty-po-lecheniyu-rasstroystv-svyazannykh-s-upotrebleniem-narkotikov/https://harmreduction.eu/resources/prisons/drug-situation-in-european-prisons/https://harmreduction.eu/resources/prisons/evaluation-of-the-training-course/https://harmreduction.eu/resources/prisons/evaluation-of-the-training-course-inmates/https://harmreduction.eu/resources/prisons/evaluation-of-the-training-course-trainers-sheet/https://harmreduction.eu/resources/prisons/exercise-dirty-words/https://harmreduction.eu/resources/prisons/exercise-negotiation-skills/https://harmreduction.eu/resources/prisons/exercise-safe-or-not/https://harmreduction.eu/resources/prisons/exercise-simulation-of-a-stressful-situation/https://harmreduction.eu/resources/prisons/exercise-the-matter-of-hygiene/https://harmreduction.eu/resources/prisons/exercise-the-safer-sex-debate/https://harmreduction.eu/resources/prisons/exercise-work-sharing/https://harmreduction.eu/resources/prisons/exercise-for-prison-staff-and-inmates-talking-about-drugs/https://harmreduction.eu/resources/prisons/exercise-for-staff-prison-only-abstinence-risk-reduction/https://harmreduction.eu/resources/prisons/exercise-for-staff-prison-only-health-risk/https://harmreduction.eu/resources/prisons/harm-reduction-and-ost-in-prison-what-is-clear-what-are-the-barriers-what-is-new/https://harmreduction.eu/resources/prisons/harm-reduction-in-prison-and-in-the-criminal-justice-system-heino-stover/https://harmreduction.eu/resources/prisons/harm-reduction-tasks-implemented-by-the-polish-prison-health-service-pl/https://harmreduction.eu/resources/prisons/health-and-social-responses-to-drug-problems-linda-montanari/https://harmreduction.eu/resources/prisons/how-to-evaluating-training-seminars/https://harmreduction.eu/resources/prisons/implementing-condoms-distribution-in-czech-prisons/https://harmreduction.eu/resources/prisons/infectious-diseases-in-the-context-of-human-rights/https://harmreduction.eu/resources/prisons/interventions-targeting-drug-use-and-related-problems-in-europe-implementation-of-ost-in-the-european-prisons/https://harmreduction.eu/resources/prisons/best-practice-model-in-luxembourg/https://harmreduction.eu/resources/prisons/updated-european-mapping-of-harm-reduction-interventions-in-prisons/https://harmreduction.eu/resources/prisons/naloxone-saves-lives/https://harmreduction.eu/resources/prisons/pilot-condom-distribution-in-czech-prison/https://harmreduction.eu/resources/prisons/pnsp-evaluation-questionnaire-for-prison-staff/https://harmreduction.eu/resources/prisons/pnsp-evaluation-questionnaire-for-prisoners/https://harmreduction.eu/resources/prisons/pre-implementation-pnsp-checklist/https://harmreduction.eu/resources/prisons/presentation-group-work-medical-ethics-in-prison/https://harmreduction.eu/resources/prisons/presentation-and-group-work-hiv-prevention-and-harm-reduction-in-prison/https://harmreduction.eu/resources/prisons/prevention-of-communicable-diseases-in-prison/https://harmreduction.eu/resources/prisons/prison-drug-using-situations-how-and-when-to-intervene/https://harmreduction.eu/resources/prisons/public-health-guidance-on-prevention-and-control-of-communicable-diseases-in-prison/https://harmreduction.eu/resources/prisons/seminar-2-programme-english/https://harmreduction.eu/resources/prisons/seminarium-2-program-polski/https://harmreduction.eu/resources/prisons/standards-for-the-treatment-of-drug-use-disorders/https://harmreduction.eu/resources/prisons/substitution-guidelines/https://harmreduction.eu/resources/prisons/the-bleach-procedure/https://harmreduction.eu/resources/prisons/the-instruction-how-to-self-injected/https://harmreduction.eu/resources/prisons/the-instruction-how-to-use-condom/https://harmreduction.eu/resources/prisons/the-iodine-procedure/https://harmreduction.eu/resources/prisons/the-luxembourg-paper-on-pnsp/https://harmreduction.eu/resources/prisons/the-top-12-questions-about-hepatitis-c/https://harmreduction.eu/resources/prisons/undergraduate-prisoner-students-majoring-in-social-work-pl/https://harmreduction.eu/resources/prisons/analiziruem-fakty-o-vichspide/https://harmreduction.eu/resources/prisons/kipyachenie-inektsionnogo-oborudovaniya/https://harmreduction.eu/resources/prisons/kursi-z-rozvitku-sotsialnikh-ta-zhittevikh-navichok-dlya-uvyaznenikh/https://harmreduction.eu/resources/prisons/metadon-osnovy/https://harmreduction.eu/resources/prisons/modelirovanie-stressovoy-situatsii-predstavte-chto/https://harmreduction.eu/resources/prisons/navyki-vedeniya-peregovorov/https://harmreduction.eu/resources/prisons/netsenzurnye-slova/https://harmreduction.eu/resources/prisons/prezentatsiya-i-gruppovaya-rabota-meditsinskoy-etike-v-tyurme/https://harmreduction.eu/resources/prisons/prezentatsiya-i-gruppovaya-rabota-ozt-v-tyurmakh/https://harmreduction.eu/resources/prisons/prezentatsiya-i-gruppovaya-rabota-profilaktika-vich-i-snizhenie-vreda-v-tyurmakh/https://harmreduction.eu/resources/prisons/profilaktika-infektsionnykh-zabolevaniy-v-tyurme/https://harmreduction.eu/resources/prisons/uprazhneniya-dlya-personala-tyurmy-i-zaklyuchennykh-pogovorim-o-narkotikakh/https://harmreduction.eu/resources/prisons/staying-alive-on-the-outside/https://harmreduction.eu/resources/prisons/access-to-hcv-related-services-in-prison-settings-in-europe-a-community-perspective/https://harmreduction.eu/resources/prisons/five-questions-concerning-managing-hepatitis-c-in-the-justice-system-finding-practical-solutions-for-hepatitis-c-virus-elimination/https://harmreduction.eu/resources/prisons/access-to-hepatitis-c-testing-and-treatment-for-people-who-inject-drugs-and-people-in-prisons-a-global-perspective-policy-brief/https://harmreduction.eu/resources/prisons/my-first-48-hours-out-drug-users-perspectives-challenges-and-strategies-upon-release-prison/https://harmreduction.eu/resources/other-populations/https://harmreduction.eu/resources/other-populations/inwork-tool-box/https://harmreduction.eu/resources/other-populations/frequent-experience-of-discrimination-among-people-who-inject-drugs-links-with-health-and-wellbeing/https://harmreduction.eu/resources/other-populations/novel-health-systems-service-design-checklist-to-improve-healthcare-access-for-marginalised-underserved-communities-in-europe/https://harmreduction.eu/resources/social-work/2022-01-03https://harmreduction.eu/resources/social-work/new-emcdda-manual-and-training-courses-for-professionalising-drug-prevention/https://harmreduction.eu/resources/social-work/the-recovery-village/https://harmreduction.eu/resources/social-work/drugrehabcom/https://harmreduction.eu/resources/social-work/drug-use-health-consequences/https://harmreduction.eu/resources/social-work/transforming-lives-and-empowering-communities-evidence-hrm-reduction-and-a-holistic-approach-to-people-who-use-drugs-wolters-kluwer-health-inc/https://harmreduction.eu/resources/social-work/safer-injection-video-series/https://harmreduction.eu/resources/social-work/tripapp-guide-to-a-safer-journey/https://harmreduction.eu/resources/social-work/drug-decriminalization-policyliterature-review-modelsimplementation-and-outcomes/https://harmreduction.eu/resources/social-work/nlo-service-design-checklist/https://harmreduction.eu/resources/social-work/nlo-joint-statementimprovinghealthcare-accessfor-marginalised-people/https://harmreduction.eu/resources/social-integration/https://harmreduction.eu/resources/unassigned/https://harmreduction.eu/resources/ost/https://harmreduction.eu/resources/synthetic-opioid-research/2022-01-03https://harmreduction.eu/resources/synthetic-opioid-key-responses/2022-01-03https://harmreduction.eu/resources/synthetic-opioid-dissemination/2022-03-31https://harmreduction.eu/resources/synthetic-opioid-dissemination/so-prep-project-leaflet/https://harmreduction.eu/resources/synthetic-opioid-dissemination/so-prep-project-background-and-summary/https://harmreduction.eu/resources/synthetic-opioid-dissemination/guidelines-and-recommendations-on-national-synthetic-opioid-preparedness-in-european-countries/2022-03-31https://harmreduction.eu/resources/synthetic-opioid-dissemination/final-report-on-synthetic-opioid-preparedness/2022-03-31https://harmreduction.eu/resources/synthetic-opioid-health-systems/2022-01-03https://harmreduction.eu/resources/synthetic-opioid-health-systems/report-eu-good-practices-generic-health-emergency-preparedness-protocols/https://harmreduction.eu/resources/synthetic-opioid-health-systems/report-good-practices-synthetic-opioid-preparedness-and-needs-and-challenges-eu-member-states/https://harmreduction.eu/resources/synthetic-opioids-key-resources/2022-01-02https://harmreduction.eu/resources/synthetic-opioids-key-resources/are-we-facing-opioid-crisis-europe/https://harmreduction.eu/resources/synthetic-opioids-key-resources/new-synthetic-opioids-part-new-addiction-landscape/https://harmreduction.eu/resources/synthetic-opioids-key-resources/fentanyl-epidemic-estonia-factors-its-evolution-and-opportunities-comprehensive-public-health-response-scoping-review/https://harmreduction.eu/resources/synthetic-opioids-key-resources/swedish-national-threat-assessment-fentanyl-analogues-and-other-synthetic-opioids/https://harmreduction.eu/resources/synthetic-opioids-key-resources/future-fentanyl-and-other-synthetic-opioids/https://harmreduction.eu/resources/synthetic-opioids-key-resources/global-smart-update-growing-complexity-opioid-crisis/https://harmreduction.eu/resources/synthetic-opioids-key-resources/fentanils-and-synthetic-cannabinoids-driving-greater-complexity-drug-situation/https://harmreduction.eu/resources/synthetic-opioids-key-resources/new-psychoactive-substances-global-markets-glocal-threats-and-covid-19-pandemic/https://harmreduction.eu/resources/synthetic-opioids-key-resources/europe-facing-opioid-epidemic-what-does-european-monitoring-data-tell-us/https://harmreduction.eu/courses/2021-08-19https://harmreduction.eu/courses/naloxone-on-release/2022-03-27https://harmreduction.eu/courses/naloxone-on-release/introduction/2022-04-04https://harmreduction.eu/courses/naloxone-on-release/introduction/basic-information-and-syllabus/2021-08-19https://harmreduction.eu/courses/naloxone-on-release/introduction/opioid-overdose/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/naloxone/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/naloxone/what-is-naloxone/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/naloxone/naloxone-in-european-countries/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/naloxone/naloxone-in-european-countries-continued/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/the-scottish-model/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/the-scottish-model/context-and-introduction/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/the-scottish-model/the-scottish-model-practical-steps/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/the-scottish-model/peer-education-effectiveness-and-areas-of-improvement/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/the-scottish-model/implementation-guide-policy-makers/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/the-scottish-model/implementation-guide-practitioners/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/additional-materials/2021-12-29https://harmreduction.eu/courses/naloxone-on-release/additional-materials/my-first-48-hours-out/2022-03-27https://harmreduction.eu/courses/naloxone-on-release/additional-materials/overdose-prevention-bibliography-and-references/2021-12-30https://harmreduction.eu/courses/naloxone-on-release/additional-materials/use-of-naloxone-followup-interviewreport/2021-12-30https://harmreduction.eu/courses/naloxone-on-release/additional-materials/naloxone-poster-and-leaflet/2021-12-30https://harmreduction.eu/courses/naloxone-on-release/additional-materials/overdose-prevention-intervention-and-naloxone-awareness-session/2021-12-30https://harmreduction.eu/courses/naloxone-on-release/additional-materials/naloxone-training-sample-certificate/2021-12-30https://harmreduction.eu/courses/naloxone-on-release/additional-materials/session-evaluation-template/2021-12-30https://harmreduction.eu/courses/naloxone-on-release/additional-materials/implementation-checklist-for-policy-makers-and-practitioners/2021-12-30https://harmreduction.eu/courses/naloxone-on-release/additional-materials/naloxone-training-for-trainers/2021-12-30https://harmreduction.eu/courses/naloxone-on-release/additional-materials/one-to-one-naloxone-training-checklist/2021-12-30https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/2021-08-19https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/2022-04-04https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/the-biology-of-hiv/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/the-biology-of-the-hepatitis-c-virus-hcv/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/hiv-transmission/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/hcv-transmission/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/screening-and-diagnosis-for-hiv/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/screening-and-diagnosis-of-hcv/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/hiv-treatement-and-drug-use/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/treatment-for-hcv/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/tuberculosis/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/about-hiv-hcv-tb/hiv-hcv-tb-additional-resources/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/different-types-of-tests/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/different-types-of-tests/antibody-screening-test/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/different-types-of-tests/rapid-test/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/different-types-of-tests/follow-up-diagnostic-test-for-hiv/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/different-types-of-tests/follow-up-diagnostic-test-for-hcv/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/different-types-of-tests/new-types-of-test-home-testself-testing-and-self-sampling-test/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/different-types-of-tests/different-types-of-tests-additional-resources/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/pre-and-post-test-counselling/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/pre-and-post-test-counselling/pre-and-post-test-counselling-introduction/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/pre-and-post-test-counselling/principles-of-pre-post-test-counselling/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/pre-and-post-test-counselling/two-components-of-hivhcv-counselling/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/pre-and-post-test-counselling/informed-consent-and-risk-assessment/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/pre-and-post-test-counselling/post-test-counselling-and-communication-of-test-results/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/pre-and-post-test-counselling/ethical-considerations-and-importance-of-training/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/pre-and-post-test-counselling/counselling-additional-resources/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/developing-services-and-attracting-clients/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/developing-services-and-attracting-clients/attracting-clients-introduction/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/developing-services-and-attracting-clients/low-threshold-services/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/developing-services-and-attracting-clients/harm-reduction-philosophy/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/developing-services-and-attracting-clients/peer-involvement/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/developing-services-and-attracting-clients/attracting-clients-additional-resources/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/2022-04-04https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/gender-specific-approach-introduction/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/alcohol-other-drugs-and-pregnancy/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/contraception-in-wud/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/harm-reduction-during-pregnancy/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/opioid-substitution-therapy/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/women-who-use-drugs-hiv-and-hepatitis/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/violence-agains-women-who-use-drugs/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/wud-in-prison-settings/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/gender-specific-approach-recommendations/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/gender-specific-approach/gender-specific-approach-additional-resources/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/linkage-to-care/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/linkage-to-care/linkage-to-care-introduction/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/linkage-to-care/integrated-care/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/linkage-to-care/barriers-to-linkage/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/linkage-to-care/what-can-be-done-to-support-integrated-care/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/linkage-to-care/linkage-to-care-additional-resources/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/improving-quality/2022-03-20https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/improving-quality/what-is-quality-improvement/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/improving-quality/quality-improvement-tools/2022-03-26https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/counselling-testing-in-prison/2022-04-04https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/counselling-testing-in-prison/prison-as-places-for-public-health-interventions/2022-03-27https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/counselling-testing-in-prison/voluntary-counseling-and-testing-standards-vct-in-prison/2022-03-27https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/counselling-testing-in-prison/linkage-to-care-in-prison-settings/2022-03-27https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/counselling-testing-in-prison/developing-an-exemplary-intervention-in-germany/2022-03-27https://harmreduction.eu/courses/hiv-and-hcv-rapid-testing-in-low-threshold-settings-for-pwud/counselling-testing-in-prison/prison-settings-additional-resources/2022-03-27https://harmreduction.eu/so-prep/2022-03-31https://harmreduction.eu/gphn-tools/2022-07-16https://harmreduction.eu/gphn-tools/aids-conference-2022-workshop/2022-07-28https://harmreduction.eu/gphn-tools/aids-conference-2022-workshop/quizzes/2022-07-30https://harmreduction.eu/gphn-tools/aids-conference-2022-workshop/quizzes/quiz-1/2022-08-08